Bruker Detection Corporation today announced that it has advanced to the last phase of the Department of Homeland Security (DHS) Autonomous Rapid Facility Chemical Agent Monitor (ARFCAM) Research & Development Program which is intended to develop the 3rd generation chemical detection capability for critical infrastructure.
Bruker's ARFCAM is a gas trace detector for the detection of chemical warfare agents (CWAs) and toxic industrial chemicals (TICs) based on Bruker's proprietary RAIDTM Ion Mobility Spectrometry (IMS) technology. The ARFCAM is specifically designed for long-term monitoring of ambient air for the presence of hazardous chemical vapors in the interior or exterior of critical government buildings, subways, airports and other facilities.
With its own R&D investment, Bruker has also developed a novel, combined Drugs and Explosives trace detector, called the DE-tectorTM, for airport and other check-point applications. The DE-tector uses Bruker's next-generation RAID IMS technology with breakthrough improvements in technology and 
detection algorithms for even further improved detection capabilities, specificity and analytical robustness. The DE-tector, which is being launched in 2010, is expected to represent a major leap forward in explosives trace detection using next-generation IMS technology with selectivity and specificity that approaches that of mass spectrometry. The DE-tectorcontinues to benefit from the high sensitivity, robust and easy operation, small size and relatively low cost of previous Bruker high-performance IMS systems.
Mr. Frank Thibodeau, Vice President of Bruker Detection Corporation, commented: "The ARFCAM R&D program consisted of a challenging competitive and incremental development of chemical detection technology under demanding environments which pushed the limits of chemical point detection systems. The Bruker ARFCAM prototype has performed very well in this development program and has been selected by the U.S. Department of Homeland Security for final development and field testing in Phase IIIb. We are delighted to have been selected for the final phase of ARFCAM, and believe that Bruker's robust and proven RAID IMS technology, unsurpassed detection capability, and proprietary industry-leading false-alarm suppression have led to this award. These technological features are also built into our industry-leading RAID-M handheld detector, RAID-XP portable combined chemical and gamma radiation detector, RAID-S2 shipboard detector, as well as our RAID-AFM Autonomous Facility Monitor for critical building and infrastructure protection."
About Bruker Detection Corporation Bruker Corporation (Nasdaq: BRKR, a Delaware corporation), headquartered in Billerica, Massachusetts, is the NASDAQ publicly traded parent company of Bruker Detection Corporation. From the beginning almost fifty years ago, Bruker has been driven by a singleea: to provide the best technological solution for each analytical task. Today, Bruker employs more than 500 people in the United States and more than 4,000 employees worldwide at over 70 locations on all continents. Bruker generates over $250 million in revenue in the US alone, and over $1 billion in revenue globally. More than 75% of its shareholders are American institutions and citizens.
Bruker systems cover a broad spectrum of applications in all fields of research and development and are used in industrial production processes for the purpose of ensuring quality and process reliability. Bruker continues to build upon its extensive range of products and solutions, its broad base of installed systems and a strong reputation amongst its customers. Staying ahead of our competition demands an investment in our most important resource: our people, and we continue to invest a large portion of our profits in Research and Development, as well as continuously expand customer support efforts. For more information about Bruker’s CBRNE Detection Business and Bruker Corporation (NASDAQ: BRKR), please visit www.bruker.com/detection
For Further Information: Frank Thibodeau, Vice President Bruker Detection Corporation Phone: 978-663-3660 x.1308 Email: fnt@bdal.com